Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991)

被引:79
作者
Espinel-Ingroff, A [1 ]
机构
[1] Virginia Commonwealth Univ, Div Infect Dis, Med Mycol Res Lab, Richmond, VA 23398 USA
关键词
D O I
10.1128/JCM.41.1.403-409.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The NCCLS M38-A document does not describe guidelines for testing caspofungin acetate (MK-0991) and other echinocandins against molds. This study evaluated the susceptibilities of 200 isolates of Aspergillus fumigatus, A. flavus, A. nidulans, A. niger, and A. terreus to caspofungin (MICs and minimum effective concentrations [MECs]) by using standard RPMI 1640 (RPMI) and antibiotic medium 3 (M3), two inoculum sizes (10(3) and 10(4) CFU/ml), and two MIC determination criteria (complete [MICs-0] and prominent growth inhibition [MICs-2]) at 24 and 48 h. Etest MICs were also determined. In general, caspofungin MIC-2 and MEC pairs were comparable with both media and inocula (geometric mean ranges of MECs and MICs, respectively, with larger inoculum: 0.12 to 0.64 mug/ml and 0.12 to 0.44 mug/ml with RPMI versus 0.04 to 0.51 mug/ml and 0.03 to 0.21 mug/ml with M3); however, MEC results were less influenced by testing conditions than MICs, especially with the larger inoculum. Overall, the agreement between caspofungin Etest MICs and broth dilution values was higher with MECs obtained with M3 (>90%) and the large inoculum than under the other testing conditions. Because RPMI is a more stable and chemically defined medium than M3, the determination at 24 h of the easier visual MECs with RPMI and the inoculum recommended in the M38-A document appears to be a suitable procedure at present for in vitro testing of caspofungin against Aspergillus spp. Future in vitro correlations with in vivo outcome of both microdilution and Etest procedures may detect more-relevant testing conditions.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 36 条
  • [1] Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice
    Abruzzo, GK
    Gill, CJ
    Flattery, AM
    Kong, L
    Leighton, C
    Smith, JG
    Pikounis, VB
    Bartizal, K
    Rosen, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) : 2310 - 2318
  • [2] Evaluation of the echinocandin antifungal MK-0991 (L-743,872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
    Abruzzo, GK
    Flattery, AM
    Gill, CJ
    Kong, L
    Smith, JG
    Pikounis, VB
    Balkovec, JM
    Bouffard, AF
    Dropinski, JF
    Rosen, H
    Kropp, H
    Bartizal, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2333 - 2338
  • [3] In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates
    Arikan, S
    Lozano-Chiu, M
    Paetznick, V
    Rex, JH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) : 327 - 330
  • [4] Quality control limits for broth microdilution susceptibility tests of ten antifungal agents
    Barry, AL
    Pfaller, MA
    Brown, SD
    Espinel-Ingroff, A
    Ghannoum, MA
    Knapp, C
    Rennie, RP
    Rex, JH
    Rinaldi, MG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) : 3457 - 3459
  • [5] In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
    Bartizal, K
    Gill, CJ
    Abruzzo, GK
    Flattery, AM
    Kong, L
    Scott, PM
    Smith, JG
    Leighton, CE
    Bouffard, A
    Dropinski, JF
    Balkovec, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2326 - 2332
  • [6] Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: Results from a multicenter prospective study of candidemia
    Clancy, CJ
    Nguyen, MH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) : 1289 - 1290
  • [7] In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds
    DelPoeta, M
    Schell, WA
    Perfect, JR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) : 1835 - 1836
  • [8] Itraconazole resistance in Aspergillus fumigatus
    Denning, DW
    Venkateswarlu, K
    Oakley, KL
    Anderson, MJ
    Manning, NJ
    Stevens, DA
    Warnock, DW
    Kelly, SL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1364 - 1368
  • [9] Introduction to antifungal drugs
    Dismukes, WE
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (04) : 653 - 657
  • [10] In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods
    Ernst, EJ
    Klepser, ME
    Ernst, ME
    Messer, SA
    Pfaller, MA
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (02) : 75 - 80